Approval · Notice of Compliance 22364 · 2019
INTRON A: Notice of Compliance 22364
Issued July 5, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 22364
- Date
- July 5, 2019
- Company
- Merck Canada IncKirkland, Quebec, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Labelling Only
- Reason
- Labelling updates
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| INTRON A | Not yet assigned | — |
Medicinal ingredients
- INTERFERON ALFA 2B 6,000,000 UNIT per ML
- INTERFERON ALFA 2B 10,000,000 UNIT per ML
- INTERFERON ALFA 2B 10,000,000 UNIT per VIAL